Search
for
Sort by
Research 211–240 of 772
- Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Ruxolitinib: A novel molecule in the management of dermatological disorders
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Modern dermatology brings treatment even for alopecia areata
- Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Alopecia areata
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Alopecia Areata: Current Review
- A review of Janus kinase inhibitor use in scarring alopecia
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Baricitinib as a treatment for myasthenia gravis: A case report
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series